Darrell Sleep

Provell Pharmaceuticals LLC is a healthcare company, which engages in marketing and distribution of pharmaceutical products. It offers products of Merck KGaA including Euthyrox. The company was founded by Jim Small and Kurt Kalm in 2005 and is headquartered in Honey Brook, PA.

Cobra Biomanufacturing Plc manufactures biological products for clinical studies and clients in the pharmaceutical and biotech industries. It designs and manufactures novel proteins, viruses and additional cell products. It provides DNA-based technologies, services and products. Its services include: DNA, virus and protein manufacturing, cell banking, process development, analytical services and quality assurance and regulatory support. It uses mammalian and microbial host cells for numerous therapeutic protein developments. It also provides a range of DNA maintenance technology, such as its ORT, ORT-VAC and RiboCLEAR programs. The company is headquartered in Newcastle, the United Kingdom.

MetCon Medicin AB develops and manufactures pharmaceutical products. Its products are used for oral administration and stabilizing blood sugar levels. The company's products are used for the treatment of diabetes and other metabolic diseases. MetCon Medicin was founded by Dr. Ulf Smith and Dr. Mats Lake in 1999 and is headquartered in Lidingo, Sweden.

The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson.

Part of Recipharm AB, Recipharm Monts SAS is a company that manufactures sterile injectable anesthetic products. The company is based in Monts, France. Carl Ericson has been the CEO of the French company since 2019.

OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden.

KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.

SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden.

Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom.

SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden.

Octapharma AB manufactures and distributes pharmaceutical products. Its products used for treatment in coagulation disorders, immune disease, and intensive care and emergency medicine. The company operates as a subsidiary of Octapharma AG. Octapharma was founded in 1997 and is located in Stockholm, Sweden.

Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom.

Part of Viatris, Inc., Recip AB is a company that manufactures pharmaceutical products. Recip AB is based in Arsta, Sweden. Recip was acquired by Meda AB, part of Viatris, Inc. from August 24, 2016 on December 31, 2007 for $475.65 million.

Zentricity International AB provides investment services. The private company is based in Stockholm, Sweden.

Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden.

Part of Recipharm AB, Aesica Holdco Ltd. operates as a holding British company. The company is based in Hemel Hempstead, UK.

Part of Recipharm AB, Recipharm Fontaine SAS is a French pharmaceutical company that manufactures pharmaceutical products. The company is based in Fontaine-les-Dijon, France. The company was founded in 2008. Pascal Prudent has been the CEO of the company since 2017.

Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest.

Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden.

Bohus BioTech AB is a Swedish company that manufactures and develops hyaluronic acid products. The company is based in Stromstad, Sweden and has subsidiaries in Sweden. The company was founded in 1992 by Daniel C. Ogbonnaya.

Zentricity Holding AB provides investment services. It offers venture capital to startup companies. The company is headquartered in Stockholm, Sweden.

Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden.

Flerie Participation AB is an investment holding Swedish company. The company is based in Stockholm, Sweden.

Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom.

Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands.

Part of Recipharm AB, Recipharm Verwaltungs GmbH is an investment holding German company. The company is based in Wasserburg am Inn, Germany. The CEOs of the company are Michael Isele, Thomas Bengt Eldered.

Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018.

Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom.

Part of Recipharm AB, Consort Medical GmbH is a German company that functions as an investment holding company. The company is based in Monheim, Germany. The CEO of the company is Thomas Bengt Eldered.

Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château.

NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023.

Epicyt Pharma AB is a Swedish pharmaceutical research company that was founded in 2016 by Ville Wallenius and Lars Fändriks. The company is based in Mölndal, Sweden. Epicyt Pharma develops the drug candidate BAFA.